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INTRODUCTION
Paclitaxel, an anti‑microtubule agent originally isolated from the 
bark of the Pacific yew tree (Taxus brevifolia), is widely used to treat 
solid neoplasms such as ovarian, breast, and lung cancers.[1,2] However, 
paclitaxel causes peripheral neuropathy, which is characterized by pain 
and allodynia, with a stocking‑and‑glove distribution.[3] The peripheral 
neuropathy is a major dose‑limiting side effect of paclitaxel. Several 
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ABSTRACT
Peripheral neuropathy is a major dose‑limiting side effect of the chemotherapeutic agent paclitaxel. This study examined whether the 
three related traditional herbal formulations, goshajinkigan (GJG; 牛車腎氣丸 Niú Chē Shèn Qì Wán), hachimijiogan (HJG; 八味地黃
丸 Bā Wèi Dì Huáng Wán), and rokumigan (RMG; 六味丸 Liù Wèi Wán), would relieve paclitaxel‑induced mechanical allodynia in mice. 
A single intraperitoneal injection of paclitaxel (5 mg/kg) induced mechanical allodynia, which peaked on day 14 after injection. On day 14 
after paclitaxel injection, oral administration of GJG (0.1‑1.0 g/kg) produced a significant inhibition of established allodynia, but HJG and 
RMG did not affect the allodynia. Repeated oral administration of GJG (0.1‑1.0 g/kg) starting from the day after paclitaxel injection did 
not affect allodynia development, but significantly inhibited allodynia exacerbation. Repeated oral administration of HJG produced a slight 
inhibition of allodynia exacerbation, but that of RMG did not. These results suggest that prophylactic administration of GJG is effective in 
preventing the exacerbation of paclitaxel‑induced allodynia. The herbal medicines Plantaginis Semen (車前子 Chē Qián Zǐ) and Achyranthis 
Radix (牛膝 Niú Xī), which are present in GJG but not in HJG, may contribute to the inhibitory action of GJG on the exacerbation of 
paclitaxel‑induced allodynia.
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drugs, such as gabapentin and amifostine, were tested and failed to 
relieve paclitaxel‑induced peripheral neuropathy in patients.[4‑6]
Goshajinkigan (GJG; 牛車腎氣丸 Niú Chē Shèn Qì Wán) is 
a traditional herbal formulation consisting of 10 herbal medicines 
[Rehmanniae Radix (地黃 Dì Huáng), Achyranthis Radix (牛膝 
Niú Xī), Corni Fructus (山茱萸 Shān Zhū Yú), Dioscoreae Rhi-
zoma (山藥 Shān Yào), Plantaginis Semen (車前子 Chē Qián Zǐ), 
Alismatis Rhizoma (澤瀉 Zé Xiè), Poria (茯苓 Fú Ling), Moutan 
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Cortex (牡丹皮 Mǔ Dān Pí), Cinnamoni Cortex (桂皮 Guì Pí), 
and Processi Aconiti Radix (附子 Fù Zǐ)]. GJG is used for the 
treatment of several neurological symptoms including pain 
and dysesthesia (unpleasant abnormal sensation). It has been 
demonstrated to be effective against chemotherapy‑induced 
peripheral neuropathy in cancer patients.[7,8] Recent studies have 
shown that GJG does not attenuate the antineoplastic action 
of chemotherapeutic agents.[9,10] Excluding Achyranthis Radix 
and Plantaginis Semen, hachimijiogan (HJG; 八味地黃丸 Bā 
Wèi Dì Huáng Wán) consists of the same herbal medicines 
found in GJG, and rokumigan (RMG; 六味丸 Liù Wèi Wán) 
consists of all herbal medicines found in HJG, excluding Cin-
namoni Cortex (桂皮 Guì Pí) and Processi Aconiti Radix (附子 
Fù Zǐ). There is no clinical evidence of the effects of HJG and 
RMG on chemotherapy‑induced peripheral neuropathy. In this 
study, we investigated the effects of GJG, HJG, and RMG on 
paclitaxel‑induced mechanical allodynia.
MATERIALS AND METHODS
Animals
Male C57BL/6NCr mice (Japan SLC Ltd, Hamamatsu, 
Japan) were used. All animals were 6 weeks old at the start of 
the experiments. They were housed in a room with controlled 
temperature (21‑23°C), humidity (45‑65%), and a 12‑h light/dark 
cycle (lights on from 7:00 a.m. to 7:00 p.m.). Food and water were 
provided ad libitum. Experiments were performed after obtain‑
ing approval from the animal care committee of the University 
of Toyama.
Drugs
Paclitaxel purchased from Sigma‑Aldrich (St Louis, MO, 
USA) was dissolved in vehicle [physiological saline containing 
10% Cremophor® EL (Sigma‑Aldrich) and 10% ethanol]. Pacli‑
taxel and the vehicle were administered intraperitoneally; the 
dose (5 mg/kg) was selected from a published report[11] and was 
in accordance with the recommended clinical dose of 210 mg/m2 
body surface area, which corresponds to a dose of 5.9 mg/kg in a 
person of 170 cm body height and 60 kg weight. Dried extracts of 
GJG (Lot. No. 2080107010, 2009), HJG (Lot. No. 2090007010, 
2009), and RMG (Lot. No. 2090087010, 2009) were obtained 
from Tsumura and Co., Ltd (Tokyo, Japan). These dried extracts 
were dissolved in 5% gum arabic and were administered orally 
once on day 14 after the paclitaxel injection or once daily from 
the day after paclitaxel injection is given.
Behavioral experiments
Mechanical allodynia in the hind paw was evaluated using 
a von Frey filament (North Coast Medical Inc., Morgan Hill, 
CA, USA), as described.[11] After an acclimation period of at least 
30 min, a fine von Frey filament with a bending force of 0.69 mN 
was applied perpendicularly against the central part of the plantar 
hind paw and was held for 1‑3 s with it slightly bent. Responses to 
the stimuli were scored as follows: 0, no reaction; 1, lifting of the 
hind paw; and 2, licking and flinching of the hind paw. A stimulus 
of the same intensity was applied three times alternately to each 
hind paw at intervals of several seconds, and the average response 
score served as the allodynia score (the maximum score was 2). 
When the effects of single administration of dried extracts of 
traditional formulations were examined on day 14 after paclitaxel 
injection, mechanical allodynia was evaluated before and after 
the administration of traditional formulations. When the effects 
of repeated administrations of the dried extracts were examined, 
mechanical allodynia evaluation was performed before each ad‑
ministration of traditional formulations.
Statistical analysis
All data are presented as mean ± standard error of the mean. 
Statistical significance was analyzed using two‑way repeated 
measures analysis of variance (ANOVA) and post hoc Holm‑Sidak 
multiple comparison test. A P < 0.05 was considered statisti‑
cally significant. The statistical analyses were performed using 
SigmaPlot™ graphing and statistical software version 11 (Systat 
Software, Inc., Chicago, IL, USA).
RESULTS
Paclitaxel‑induced mechanical allodynia
A single intraperitoneal injection of paclitaxel (5 mg/kg) caused 
mechanical allodynia, which became apparent on day 4 after injec‑
tion, peaked on day 14, and almost subsided by day 21 [Figure 1a; 
main effect of paclitaxel treatment, F
1,10
 = 87.676, P < 0.001; 
interaction between paclitaxel treatment  and time, F
30,300
 = 12.286, 
P < 0.001 (two‑way repeated measures ANOVA)].
Effects of single administration of GJG, HJG, and RMG on 
paclitaxel‑induced mechanical allodynia
Three formulations were administered orally on day 14 after 
paclitaxel injection. Single administration of GJG (0.1‑1.0 g/kg) 
exerted a relatively short‑lasting but significant dose‑dependent 
inhibition on the established mechanical allodynia; two‑way 
repeated measures ANOVA revealed a significant main effect of 
GJG (F
3,20
 = 3.611, P = 0.031) [Figure 1b]. Single administration 
of HJG and RMG did not affect the established mechanical al‑
lodynia at doses of 0.1‑1.0 g/kg [Figure 1c and d].
Effects of prophylactic administration of GJG, HJG, and 
RMG on paclitaxel‑induced mechanical allodynia
In this series of experiments, three formulations were admin‑
istered daily from the day after paclitaxel injection. Repeated 
administration of GJG (0.1‑1 g/kg) did not affect the initial 
development of mechanical allodynia induced by paclitaxel, 
but significantly inhibited the exacerbation of allodynia from 
day 9 after paclitaxel injection, in comparison with the vehicle, 
although no clear dose‑dependency was observed [Figure 2a; 
interaction between paclitaxel treatment and time, F
42,252
 = 1.889, 
P = 0.002 (two‑way repeated measures ANOVA)]. Similarly, 
repeated administration of HJG (0.1‑1 g/kg) did not affect the 
initial development of mechanical allodynia, but the highest 
dose of HJG (1 g/kg) significantly inhibited allodynia on day 14 
after the injection, in comparison with the vehicle [Figure 2b; 
interaction between paclitaxel treatment and time, F
42,266
 = 1.504, 
P = 0.03 (two‑way repeated measures ANOVA)]. Repeated ad‑
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decreased activity of the descending noradrenergic and serotonergic 
systems. It is possible that paclitaxel decreases the activity of the 
descending noradrenergic and/or serotonergic systems.
Prophylactic repeated administration of GJG inhibited 
paclitaxel‑induced mechanical allodynia. GJG consists of the 
following 10 herbal medicines: Rehmanniae Radix (地黃 Dì 
Huáng), Corni Fructus (山茱萸 Shān Zhū Yú), Dioscoreae 
Rhizoma (山藥 Shān Yào), Alismatis Rhizoma (澤瀉 Zé Xiè), 
Poria (茯苓 Fú Ling), Moutan Cortex (牡丹皮 Mǔ Dān Pí), Cin-
namoni Cortex (桂皮 Guì Pí), Processi Aconiti Radix (附子 Fù Zǐ), 
Achyranthis Radix (牛膝 Niú Xī), and Plantaginis Semen (車前子 
Chē Qián Zǐ); HJG consists of the first 8 of these herbal medicines 
and RMG consists of the first 6 of these medicines. The results 
showed that HJG had only a slight effect at the highest dose 
tested and RMG did not have a prophylactic effect, suggesting 
that Plantaginis Semen and/or Achyranthis Radix play a role in 
the prophylactic activity of GJG. The underlying mechanisms are 
unclear, and allodynia‑preventing substances have not yet been 
isolated from the extracts of these two herbal medicines. However, 
one possibility is that the activity of the scavengers of reactive 
oxygen species is involved in the antiallodynic activity. Although 
a single administration is ineffective, prophylactic administration 
of the reactive oxygen species scavenger N‑tert‑butyl‑a‑phenyl‑
nitrone suppresses paclitaxel‑induced mechanical allodynia.[14] 
Since Plantaginis Semen and Achyranthis Radix have antioxidant 
activity,[15‑17] this action may be involved in the prevention of an 
exacerbation of paclitaxel‑induced allodynia. Another possibility 
is the improvement of decreased blood flow. Paclitaxel, but not 
vincristine, decreases peripheral blood flow.[11] The prostaglandin 
E1 analog limaprost, which counteracts this reduction in blood 
Figure 1. Effects of single administration of goshajinkigan (GJG), hachimijiogan (HJG), and rokumigan (RMG) on the established mechanical allodynia 
after paclitaxel injection. (a) Development of mechanical allodynia after a single injection of paclitaxel. Mice were injected intraperitoneally with 
paclitaxel (5 mg/kg) or vehicle on day 0. GJG (b), HJG (c), RMG (d), or vehicle (5% gum arabic) was orally administered on day 14 after paclitaxel 
injection. Data are presented as mean and standard error of the mean (n = 5‑6). *P < 0.05 compared to vehicle (Holm‑Sidak multiple comparisons)
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ministration of RMG (0.1‑1 g/kg) did not affect the mechanical 
allodynia induced by paclitaxel [Figure 2c].
DISCUSSION
Single oral administration of GJG (0.1‑1 g/kg) exerted a 
dose‑dependent inhibition on the established mechanical allodynia 
after paclitaxel injection, whereas the GJG‑related herbal formula‑
tions HJG and RMG did not affect the established allodynia. The 
recommended clinical daily dose of GJG granules is 7.5 g, which 
contains 4.5 g of dried GJG extract. Given that the body weight is 
60 kg, the dose of the dried GJG extract is 0.075 g/kg. Thus, the 
antiallodynic dose (1 g/kg) in mice with paclitaxel‑induced neu‑
ropathy was 13 times higher than the recommended clinical dose. 
Recently, we have demonstrated that single oral administration of 
GJG (0.3 and 1.0 g/kg) inhibits the established mechanical allodynia 
after the injection of oxaliplatin, a platinum chemotherapeutic 
agent.[12] The inhibitory effect of 1 g/kg GJG on paclitaxel‑induced 
allodynia (present study) was less than that of 0.3 g/kg GJG on 
oxaliplatin‑induced allodynia.[12] The inhibitory action of GJG 
on oxaliplatin‑induced allodynia is at least in part mediated by 
the activation of the descending noradrenergic and serotonergic 
systems,[12] and in our preliminary experiment, single administra‑
tion of milnacipran, a serotonin–noradrenaline reuptake inhibitor, 
markedly inhibited the established allodynia after oxaliplatin 
injection (data not shown). In contrast, single administration of 
milnacipran does not affect the established allodynia after paclitaxel 
injection.[13] These findings, taken together, raise the possibility that 
a low efficacy of GJG in paclitaxel‑induced allodynia is due to the 
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flow without affecting normal blood flow,[18] exerts prophylactic 
inhibition on allodynia induced by paclitaxel, but not by vincris‑
tine.[11] In this study, prophylactic administration of GJG prevented 
mechanical allodynia induced by paclitaxel. In contrast, in our 
preliminary experiments, prophylactic administration of GJG did 
not prevent vincristine‑induced allodynia. GJG and its constitu‑
ent Achyranthis Radix invigorate blood circulation.[15,17,19] Taken 
together, these findings raise the possibility that the prevention of 
the decrease in peripheral blood flow contributes to the prophy‑
lactic activity of GJG.
Prophylactic administration of HJG, but not RMG, showed 
slight antiallodynic action at the highest dose tested in paclitax‑
el‑treated mice. Thus, it is possible that Cinnamoni Cortex and 
Processi Aconiti Radix also have prophylactic antiallodynic activ‑
ity. Similar to Achyranthis Radix, Cinnamoni Cortex and Processi 
Aconiti Radix invigorate blood circulation.[20,21] However, the 
prophylactic antiallodynic activity of HJG was weaker than that 
of GJG. Thus, although Cinnamoni Cortex and Processi Aconiti 
Radix may have some prophylactic antiallodynic activity, Plan-
taginis Semen and Achyranthis Radix may play important roles 
in the antiallodynic action of GJG.
CONCLUSION
Prophylactic administration of GJG prevents an exacerbation 
of paclitaxel‑induced mechanical allodynia. Since GJG also has 
acute antiallodynic activity, it may be useful for the prevention of 
paclitaxel‑induced peripheral neuropathy. Although the underlying 
mechanisms remain unclear, Plantaginis Semen and/or Achyran-
this Radix may contribute to the antiallodynic activity of GJG.
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